Rane Holdings Ltd
Rane Holdings Ltd (RANEHOLDIN) last traded at ₹1,595, a market capitalisation of ₹2,278 crore, on a P/E of 28.9. Over the past 52 weeks the stock has ranged between ₹981 and ₹1,898. Rane Holdings Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,587 crore and net profit of ₹48 crore. Figures are as of 25 Aug 2026 and are not real time.
Rane Holdings Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Rane Holdings Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,587 cr, up 18.3% from ₹1,341 cr a year earlier. Net profit was ₹48 cr, down 15.8% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 916 | 1,241 | 1,374 | 1,341 | 1,399 | 1,535 | 1,609 | 1,587 |
| Expenses | 835 | 1,162 | 1,278 | 1,239 | 1,302 | 1,492 | 1,483 | 1,480 |
| Operating profit | 81 | 78 | 95 | 102 | 97 | 42 | 126 | 107 |
| OPM % | 9% | 6% | 7% | 8% | 7% | 2.8% | 8% | 7% |
| Other income | 222 | 13 | 10 | 33 | 21 | 4 | 37 | 28 |
| Interest | 20 | 24 | 24 | 21 | 19 | 19 | 15 | 20 |
| Depreciation | 35 | 47 | 52 | 50 | 52 | 52 | 55 | 55 |
| Profit before tax | 248 | 19 | 29 | 63 | 47 | -25 | 92 | 61 |
| Tax % | 25% | 78% | 60% | 9% | 33% | 55% | 5% | 20% |
| Net profit | 185 | 4 | 12 | 57 | 31 | -40 | 88 | 48 |
| EPS (₹) | 124.44 | 2.27 | 6.58 | 35.57 | 16.45 | -35.41 | 51.94 | 26.17 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Rane Holdings Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 2,038 | 2,695 | 3,511 | 3,541 | 4,374 | 5,891 | 6,129 |
| Operating profit | 88 | 176 | 321 | 332 | 340 | 426 | 373 |
| OPM % | 4.3% | 7% | 9% | 9% | 8% | 7% | 6% |
| Net profit | -60 | 35 | 87 | 150 | 221 | 137 | 128 |
| EPS (₹) | -35.42 | 16.91 | 43.61 | 86.69 | 145.13 | 68.55 | 59.15 |
TTM is the trailing twelve months to the most recent quarter.
Rane Holdings Ltd growth and returns
- 10 Years
- 9%
- 5 Years
- 24%
- 3 Years
- 19%
- TTM
- 26%
- 10 Years
- 3%
- 5 Years
- 26%
- 3 Years
- 4%
- TTM
- 6%
- 10 Years
- 9%
- 5 Years
- 20%
- 3 Years
- 18%
- 1 Year
- 7%
- 10 Years
- 7%
- 5 Years
- 6%
- 3 Years
- 7%
- Last Year
- 7%
Rane Holdings Ltd shareholding pattern
Promoters held 46.64% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.93% and DIIs 3.39%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 46.55% | 46.55% | 46.55% | 46.55% | 46.55% | 46.55% | 46.63% | 46.64% |
| FIIs | 0.92% | 0.85% | 0.81% | 0.82% | 1.05% | 0.82% | 0.76% | 0.93% |
| DIIs | 3.14% | 3.81% | 3.84% | 3.83% | 4.03% | 4.09% | 4.11% | 3.39% |
| Public | 49.38% | 48.78% | 48.79% | 48.79% | 48.36% | 48.54% | 48.48% | 49.05% |
| No. of shareholders | 15,415 | 15,911 | 15,869 | 15,968 | 16,248 | 15,993 | 15,635 | 15,390 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Rane Holdings Ltd corporate filings
- The audio recordings of the earnings Conference call is available in the investor information section of the website of the Company at the web-link https://ranegroup.com/investor/rane- ....Company Updatelow impact
Cruxal's analysis: Rane Holdings Limited has formally submitted the audio recording of its earnings…
Read the full analysis - We enclose herewith the copy of earnings presentation. This is also being made available on the investor section of the website of the Company at the web-link: https://ranegroup.com/in ....Company Updatemedium impact
Cruxal's analysis: Rane Holdings Limited reported consolidated revenue of 1,596.9 crore for Q1 FY27…
Read the full analysis - We hereby inform that an "Earnings Conference Call" is scheduled on, Friday, August 21, 2026 at 15:00 hours (IST).Company Updatelow impact
Cruxal's analysis: Rane Holdings Limited has announced an earnings conference call scheduled for August 21…
Read the full analysis - We hereby enclose copies of the un-audited financial results for the quarter ended June 30, 2026 published in the NewspapersCompany Updatemedium impact
Cruxal's analysis: Rane Holdings Limited reported consolidated financial results for the quarter ended June…
Read the full analysis - We enclose herewith the report of scrutinizer dated August 13, 2026 in connection with 90th AGM.AGM/EGMlow impact
Cruxal's analysis: Rane Holdings Limited has successfully concluded its 90th Annual General Meeting held on…
Read the full analysis - We wish to inform you that the 90th Annual General Meeting (AGM) of the members of the Company was held on Thursday, August 13, 2026 at 15:00 hrs (IST) through VC/OAVM. In this regard, ....AGM/EGMlow impact
Cruxal's analysis: Rane Holdings Limited has successfully concluded its 90th Annual General Meeting held on…
Read the full analysis - We submit herewith the report of the Audit Committee (Monitoring Agency) dated August 13, 2026Company Updatelow impact
Cruxal's analysis: Rane Holdings Ltd has filed its Monitoring Agency Report as per Regulation 30 of the SEBI…
Read the full analysis - We submit herewith the quarterly statement of deviation / variation(s) for the period ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Rane Holdings Ltd has filed its quarterly statement of deviation or variation regarding…
Read the full analysis - Outcome of meeting of the Board of Directors held on August 13, 2026.Board Meetinghigh impact
Cruxal's analysis: Rane Holdings Limited reported consolidated revenue of 1,586.88 crore for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Rane Holdings Ltd
Cruxal reads every Rane Holdings Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.